WithdrawnNot Applicable

Study of Auditory Performance on Prosodic Tests in Cochlear Implanted Subjects Using a Fine Structure Strategy

Stopped: COVID-19

France0Started 2019-02-28

Plain-language summary

Main objective: Investigate how the FineHearing strategy of the MED-EL cochlear implant can extract prosody based solely on the frequency of the voice fundamental (F0) in speech Secondary objectives: Evaluate the time evolution of the results of prosodic tests Evaluate the time evolution of the results of differential frequency threshold test Evaluate the time evolution of vocal audiometric tests in silence and noise Evaluate the correlation between prosodic test results and frequency differential threshold results

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with MED-EL cochlear implant (Sonnet / Synchrony) * Adult patient (≥ 18 years old) speaking French * Patient having an estimate of the optimal size of the electrode for its cochlea with the MED-EL software before their implantation. * Patient with post-implant audiometry thresholds without cochlear implant \> 80 dB HL on 250 Hz, 500 Hz and 1000 Hz frequencies (no residual hearing) * Patient with vocal audiometry in quiet on Fournier's disyllabic words ≥ 70% at 6 months post-activation Exclusion criteria: * Retro-cochlear pathology: auditory neuropathy, vestibular schwannoma

What they're measuring

Prosodic test

Timeframe: at 12 month post-activation

Trial details

NCT IDNCT03694704

SponsorMED-EL Elektromedizinische Geräte GesmbH

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-04-28

View on ClinicalTrials.gov More Sensorineural Hearing Loss, Bilateral trials